Cleared Traditional

K980646 - IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLES (FDA 510(k) Clearance)

May 1998
Decision
76d
Days
Class 1
Risk

K980646 is an FDA 510(k) clearance for the IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLES. This device is classified as a Bilirubin (total And Unbound) In The Neonate Test System (Class I - General Controls, product code MQM).

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on May 6, 1998, 76 days after receiving the submission on February 19, 1998.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1113.

Submission Details

510(k) Number K980646 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 1998
Decision Date May 06, 1998
Days to Decision 76 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code MQM — Bilirubin (total And Unbound) In The Neonate Test System
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1113